Depreciation, Depletion and Amortization of IGC Pharma, Inc. from 30 Jun 2010 to 30 Jun 2025

Taxonomy & unit
us-gaap: USD
Description
The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.
Summary
IGC Pharma, Inc. quarterly and annual Depreciation, Depletion and Amortization in USD history and change rate from 30 Jun 2010 to 30 Jun 2025.
  • IGC Pharma, Inc. Depreciation, Depletion and Amortization for the quarter ending 30 Jun 2025 was $141,000, a 13% decline year-over-year.
  • IGC Pharma, Inc. annual Depreciation, Depletion and Amortization for 2024 was $618,000, a 3% decline from 2023.
  • IGC Pharma, Inc. annual Depreciation, Depletion and Amortization for 2023 was $637,000, a 3% decline from 2022.
  • IGC Pharma, Inc. annual Depreciation, Depletion and Amortization for 2022 was $657,000, a 0.92% increase from 2021.
Source SEC data
View on sec.gov
Depreciation, Depletion and Amortization, Trailing 12 Months (USD)
Depreciation, Depletion and Amortization, Quarterly (USD)
Depreciation, Depletion and Amortization, YoY Quarterly Change (%)
Depreciation, Depletion and Amortization, Annual (USD)
Depreciation, Depletion and Amortization, YoY Annual Change (%)

IGC Pharma, Inc. Quarterly Depreciation, Depletion and Amortization (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q2 2025 $141,000 -$21,000 -13% 01 Apr 2025 30 Jun 2025 10-Q 14 Aug 2025 2026 Q1
Q2 2024 $162,000 +$7,000 +4.5% 01 Apr 2024 30 Jun 2024 10-Q 14 Aug 2025 2026 Q1
Q2 2023 $155,000 -$7,000 -4.3% 01 Apr 2023 30 Jun 2023 10-Q 07 Aug 2024 2025 Q1
Q2 2022 $162,000 +$5,000 +3.2% 01 Apr 2022 30 Jun 2022 10-Q 10 Aug 2023 2024 Q1
Q2 2021 $157,000 +$80,000 +104% 01 Apr 2021 30 Jun 2021 10-Q 05 Aug 2022 2023 Q1
Q2 2020 $77,000 +$60,000 +353% 01 Apr 2020 30 Jun 2020 10-Q 11 Aug 2021 2022 Q1
Q2 2019 $61,000 $17,000 +$2,000 +13% 01 Apr 2019 30 Jun 2019 10-Q 19 Aug 2020 2021 Q1
Q1 2019 $59,000 $16,000 +$11,964 +296% 01 Jan 2019 31 Mar 2019 10-K 13 Jul 2020 2020 FY
Q4 2018 $47,036 $14,000 +$9,000 +180% 01 Oct 2018 31 Dec 2018 10-Q 12 Feb 2019 2019 Q3
Q3 2018 $38,036 $14,000 +$10,000 +250% 01 Jul 2018 30 Sep 2018 10-Q 16 Oct 2018 2019 Q2
Q2 2018 $28,036 $15,000 +$9,036 +152% 01 Apr 2018 30 Jun 2018 10-Q 09 Aug 2019 2020 Q1
Q1 2018 $19,000 $4,036 -$693 -15% 01 Jan 2018 31 Mar 2018 10-K 14 Jun 2019 2019 FY
Q4 2017 $19,693 $5,000 -$191,103 -97% 01 Oct 2017 31 Dec 2017 10-Q 12 Feb 2019 2019 Q3
Q3 2017 $210,796 $4,000 -$93,842 -96% 01 Jul 2017 30 Sep 2017 10-Q 16 Oct 2018 2019 Q2
Q2 2017 $304,638 $5,964 -$91,708 -94% 01 Apr 2017 30 Jun 2017 10-Q 03 Aug 2018 2019 Q1
Q1 2017 $396,346 $4,729 -$276,183 -98% 01 Jan 2017 31 Mar 2017 10-K 21 Jun 2018 2018 FY
Q4 2016 $672,529 $196,103 +$53,103 +37% 01 Oct 2016 31 Dec 2016 10-Q 20 Feb 2018 2018 Q3
Q3 2016 $619,426 $97,842 -$51,013 -34% 01 Jul 2016 30 Sep 2016 10-Q 17 Nov 2017 2018 Q2
Q2 2016 $670,439 $97,672 -$58,302 -37% 01 Apr 2016 30 Jun 2016 10-Q 18 Aug 2017 2018 Q1
Q1 2016 $728,741 $280,912 -$42,866 -13% 01 Jan 2016 31 Mar 2016 10-K 14 Jul 2017 2017 FY
Q4 2015 $771,607 $143,000 -$10,725 -7% 01 Oct 2015 31 Dec 2015 10-Q 21 Feb 2017 2017 Q3
Q3 2015 $782,332 $148,855 -$6,299 -4.1% 01 Jul 2015 30 Sep 2015 10-Q 21 Nov 2016 2017 Q2
Q2 2015 $788,631 $155,974 +$7,085 +4.8% 01 Apr 2015 30 Jun 2015 10-Q 16 Aug 2016 2017 Q1
Q1 2015 $781,546 $323,778 +$56,316 +21% 01 Jan 2015 31 Mar 2015 10-K 14 Jul 2016 2016 FY
Q4 2014 $725,230 $153,725 +$6,017 +4.1% 01 Oct 2014 31 Dec 2014 10-Q 16 Feb 2016 2016 Q3
Q3 2014 $719,213 $155,154 +$7,304 +4.9% 01 Jul 2014 30 Sep 2014 10-Q 13 Nov 2015 2016 Q2
Q2 2014 $711,909 $148,889 -$405 -0.27% 01 Apr 2014 30 Jun 2014 10-Q 14 Aug 2015 2016 Q1
Q1 2014 $712,314 $267,462 01 Jan 2014 31 Mar 2014 10-K 14 Jul 2015 2015 FY
Q4 2013 $147,708 01 Oct 2013 31 Dec 2013 10-Q 12 Feb 2015 2015 Q3
Q3 2013 $147,850 01 Jul 2013 30 Sep 2013 10-Q 13 Nov 2014 2015 Q2
Q2 2013 $149,294 +$65,700 +79% 01 Apr 2013 30 Jun 2013 10-Q 16 Aug 2013 2013 Q1
Q2 2012 $83,594 +$32,350 +63% 01 Apr 2012 30 Jun 2012 10-Q 16 Aug 2013 2013 Q1
Q2 2011 $51,244 -$45,200 -47% 01 Apr 2011 30 Jun 2011 10-Q/A 21 Aug 2012 2012 Q1
Q2 2010 $96,444 01 Apr 2010 30 Jun 2010 10-Q 18 Aug 2011 2011 Q1

IGC Pharma, Inc. Annual Depreciation, Depletion and Amortization (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $618,000 -$19,000 -3% 01 Apr 2024 31 Mar 2025 10-K 27 Jun 2025 2025 FY
2023 $637,000 -$20,000 -3% 01 Apr 2023 31 Mar 2024 10-K 27 Jun 2025 2025 FY
2022 $657,000 +$6,000 +0.92% 01 Apr 2022 31 Mar 2023 10-K 24 Jun 2024 2024 FY
2021 $651,000 +$173,000 +36% 01 Apr 2021 31 Mar 2022 10-K 07 Jul 2023 2023 FY
2020 $478,000 +$334,000 +232% 01 Apr 2020 31 Mar 2021 10-K 23 Jun 2022 2022 FY
2019 $144,000 +$85,000 +144% 01 Apr 2019 31 Mar 2020 10-K 14 Jun 2021 2021 FY
2018 $59,000 +$40,000 +211% 01 Apr 2018 31 Mar 2019 10-K 13 Jul 2020 2020 FY
2017 $19,000 -$377,346 -95% 01 Apr 2017 31 Mar 2018 10-K 14 Jun 2019 2019 FY
2016 $396,346 -$332,395 -46% 01 Apr 2016 31 Mar 2017 10-K 21 Jun 2018 2018 FY
2015 $728,741 -$52,805 -6.8% 01 Apr 2015 31 Mar 2016 10-K 14 Jul 2017 2017 FY
2014 $781,546 +$69,232 +9.7% 01 Apr 2014 31 Mar 2015 10-K 14 Jul 2016 2016 FY
2013 $712,314 +$38,398 +5.7% 01 Apr 2013 31 Mar 2014 10-K 14 Jul 2015 2015 FY
2012 $673,916 -$322,487 -32% 01 Apr 2012 31 Mar 2013 10-K 15 Jul 2014 2014 FY
2011 $996,403 +$211,337 +27% 01 Apr 2011 31 Mar 2012 10-K 15 Jul 2014 2013 FY
2010 $785,066 01 Apr 2010 31 Mar 2011 10-K 16 Jul 2012 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.